10QSB 1 cdtq2002.htm SECURITY AND EXCHANGE COMMISSION

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10 - QSB

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarter ended March 31, 2002

Capacitive Deionization Technology Systems, Inc.

(Formerly Far West Group, Inc.)

(Exact name of registrant as specified in its charter)

Nevada

86-0867960

(State of Jurisdiction)

(I.R.S. Employer

 

identification No.)

13636 Neutron Road, Dallas, Texas 75244-4410

(Address of Principal executive offices)

972-934-1586

(Registrant's telephone number)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

(1) yes      No  X 

(2) yes  X  No     

 

The number of shares outstanding of the registrant's $.0001 par value common stock as of April 30, 2002 was 11,136,818.

 

 

Capacitive Deionization Technology Systems, Inc.

 

Index

   

Page

Part I

Financial Information

 
       
 

Item 1

Financial statements

 
       
   

Balance Sheets as of March 31, 2002 and

 
   

December 31, 2001

3

       
   

Statements of operations for the three

 
   

months ended March 31, 2002 and 2001

4

       
   

Statements of Cash Flows for the three

 
   

months ended March 31, 2002 and 2001

5

       
   

Notes to Financial Statements

6-8

       
 

Item 2

Management's discussion and analysis

 
   

of Financial Condition and Results

 
   

of Operations

8

       

Part II

Other Information

 
       
 

Item 1

Legal

9

       
 

Item 2

Changes in securities

9

       
 

Item 3

Defaults upon senior securities

10

       
 

Item 4

Submission of matters to a vote of security holders

10

       
 

Item 5

Other information

10

       
 

Item 6

Exhibits and Reports on Form 8-K

10

       

Signature page

 

10

       
       

 

 

 

 

 

 

Part I     Financial Information

Item 1     Financial Statements

CAPACITIVE DEIONIZATION TECHNOLOGY SYSTEMS, INC.

(Formerly FarWest Group, Inc.)

BALANCE SHEETS

     

March 31,

December 31,

     

2002

2001

   

(Unaudited)

(Unaudited)

Assets

 

Current assets:

     
 

Cash

 

$   17,230 

$   1,668 

 

Accounts receivable

 

10,500 

10,500 

 

Note receivable

 

 175,000 

           - 

 

Total current assets

202,730 

12,168 

         

Furniture and equipment

 

25,294 

25,294 

 

Less accumulated depreciation

 

  (14,265)

 (13,065)

     

   11,029 

   12,229 

         
     

$213,759 

$ 24,397 

Liabilities and Stockholders' Equity (Deficit)

 

Current liabilities:

     
 

Accounts payable and accrued liabilities

$1,280,953 

$1,191,659 

 

Severance payable to shareholder

154,000 

154,000 

 

Notes payable to outside stockholders

 

135,500 

137,500 

 

Current portion of long-term debt

24,497 

23,297 

 

Payable to former subsidiary

 

     31,808 

     31,808 

 

Total current liabilities

1,626,758 

1,538,264 

         

Long-term and convertible debt

20,674 

21,874 

         

Stockholders' equity (Deficit):

     
 

Preferred stock, $.0001 par value, 20,000,000

   
 

  shares authorized; none issued and outstanding

 

Common stock, $.0001 par value, 80,000,000

   
 

  shares authorized; 11,127,520 and 10,275,901

   
 

  shares issued and outstanding

1,113 

1,027 

 

Additional paid-in capital

 

6,779,576 

6,327,752 

 

Accumulated deficit

 

(8,214,362)

(7,864,520)

 

Total stockholders' equity (Deficit)

(1,433,673)

(1,535,741)

         
     

$   213,759 

$    24,397 

See accompanying notes to financial statements.

CAPACITIVE DEIONIZATION TECHNOLOGY SYSTEMS, INC.

(Formerly FarWest Group, Inc.)

STATEMENTS OF OPERATIONS

For the Three Months Ended March 31, 2002 and 2001

(Unaudited)

     

Three months ended

     

March 31,

       

2002

2001

           

Revenues

   

$          - 

$         - 

           

Operating expenses:

       
 

Common stock and options

       
 

  issued for services:

       
 

    General and administrative

   

81,310 

87,700 

 

    Research and development

   

17,000 

12,233 

 

Research and development

   

132,781 

124,236 

 

General and administrative

       
 

  (excluding amounts applicable

       
 

  to stock and options issued

       
 

  for services each period)

   

  98,189 

   29,160 

           
       

 329,280 

 253,329 

           
 

Loss from operations

   

(329,280)

(253,329)

           

Other expenses

       
 

Interest expense

   

   (20,562)

     (2,309)

           
 

Net loss

   

$(349,842)

$(255,638)

           

Basic loss per common share:

   

$(0.03)

$0.03)

           

Weighted average common shares

       
 

Outstanding

   

10,834,187 

8,347,020 

 

 

 

 

 

See accompanying notes to financial statements.

 

CAPACITIVE DEIONIZATION TECHNOLOGY SYSTEMS, INC.

(Formerly FarWest Group, Inc.)

STATEMENTS OF CASH FLOW

For the Three Months Ended March 31, 2002 and 2001

(Unaudited)

     

2002

2001

Cash flows from operating activities:

   
 

Net Loss

$(349,842)

$(255,638)

 

Adjustments to reconcile net loss to net cash

   
 

  Used in operating activities:

   
   

Depreciation

1,200 

1,197 

   

Shares issued for services

98,310 

99,933 

   

Change in operating assets and liabilities:

   
   

  Accounts payable and accrued liabilities

    89,294 

   94,606 

         
   

Net cash used in operating activities

 (161,038)

  (59,902)

         

Cash flows from investing activities:

   
 

Sale of common shares

178,600 

24,985 

 

(Payments) Proceeds notes payable to stockholders

    (2,000)

    31,000 

         
   

Net cash provided by financing activities

  176,600 

   55,985 

         

Net increase (decrease) in cash and cash equivalents

15,562 

(3,917)

         

Cash at beginning of period

     1,668 

     4,877 

         

Cash at end of period

$  17,230 

$      960 

     

Supplemental disclosure:

   
 

Total interest paid

$    - 

$45,343 

       

Non-cash transactions:

     During 2001, the Company issued 68,800 shares of common stock for settlement of $34,400 in accounts payable.

     During 2002, the Company issued 350,000 common shares for a note receivable of $175,000 and 100,000 shares of common stock for settlement of $50,000 in accounts payable.

 

 

 

See accompanying notes to financial statements.

CAPACITIVE DEIONIZATION TECHNOLOGY SYSTEMS, INC.

(Formerly FarWest Group, Inc.)

NOTES TO FINANCIAL STATEMENTS

March 31, 2002

Note 1 - Future Operations

     The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company is reporting cumulative net losses from continuing operations since January 1, 1997 of approximately $7,700,000 as of March 31, 2002 and has utilized approximately $2,700,000 in cash from operations during the same period.

     The following is a summary of management's plan to raise capital and generate additional operating funds.

     The Company was funded initially through investment by the principal shareholder. Since 1998 funding has been through private investments including strategic alliances.

     Business opportunities for the next twelve months include international CDT systems sales to governments, major multi-national industrial corporations and U.S. pilot sales. Several opportunities are being discussed including: governments, humanitarian trust funds, industrial joint ventures, market sectors and geographic distribution agreements.

     The Company recognizes the extent of the financial investment necessary to support current business activities. There is no guarantee that the Company can complete the above-referenced financing; however, the Company is negotiating the following additional options:

  • Additional strategic investment alliances.
  • Expansion of current strategic and investment alliances.
  • An industry specific joint venture.
  • A joint venture with industry and government partners to accelerate pilot systems for the Powder River CBME Gas Wastewater Remediation Project.

     The Company is dependent upon the proceeds of private placements and strategic alliances of the Company's securities to implement its business plan and to finance its working capital requirements. Should the Company's plans or its assumptions change or prove to be inaccurate or offering proceeds are insufficient to fund the Company's operations, the Company would be required to seek additional financing sooner than anticipated. Management is confident it will be able to continue raising funds in the balance of 2002 through private placements and investment/distribution agreements.

 

 

    There can be no assurances given that the Company will be successful in generating sufficient revenues from its planned activities or in raising sufficient capital to allow it to continue as a going concern which contemplates increased operating expenses, acquisition of assets and the disposition of liabilities in the normal course of business. These factors can affect the ability of the Company to implement its general business plan including the completion of the required manufacturing facilities and continued proprietary CDT product improvements.

Note 2 - Summary of Significant Accounting Policies and Practices

     (a) Description of Business

     Capacitive Deionization Technology Systems, Inc. (Formerly FarWest Group, Inc.) (the "Company" or "CDT Systems, Inc.") was organized under the laws of the state of Nevada in July 1996 to serve as a water technology company.

     In January 1997, the Company entered into a manufacturing and marketing license agreement with Lawrence Livermore National Laboratories ("Lawrence Livermore") whereby the Company obtained the rights to Lawrence Livermore's patented Capacitive Deionization Technology ("CDT"). The company has the rights to develop and manufacture a carbon aerogel CDT product for commercial use in the desalination, filtration and purification of water. The manufacturing and marketing license is effective for the life of the patents (up to 17 years). To maintain the license the Company must make contracted annual royalty payments to Lawrence Livermore beginning at $25,000 per year, then becoming a percentage of revenue. The Company has completed development of its first release CDT unit and has also completed plans to construct a manufacturing facility in North Texas for volume production of its CDT brick prototype manufacture and construction of demonstration and pilot water treatment plants for clients.

     (b) Net Loss per Weighted Average Share

     Net loss per weighted average share is calculated using the weighted average number of shares of common stock outstanding.

     (c) Basis of Presentation

     The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-QSB of Regulations S-B. They do not include all information and footnotes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the notes to the financial statements for the year ended December 31, 2001 included in the Company's Annual Report on Form 10-KSB to be filed with the Securities and Exchange Commission. The interim unaudited financial statements should be read in conjunction with those financial statements to be included in the Form 10-KSB. In the opinion of management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the three months ended March 31, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2002

Item 2 Management's discussion and analysis of financial condition and results of operations.

     Results of operations.

          The Company did not recognize any revenue during the periods ending March 31, 2002 or 2001. Initial revenues from pilot systems are expected to occur during the second quarter of 2002. Operating expenses was $329,280 compared to the first quarter of 2001 operating expenses of $253,329. Research and development expenditures for the quarter increased from $136,469 in the first quarter of 2001 to $149,781 in the first quarter 2002. The increase in operating expenses was primarily due to an increase in legal fees

     During the first quarter 2002, a private placement of 555,000 shares of the Company's Rule 144 common stock was completed providing the Company $102,500 in cash and a note receivable of $175,000. The Company issued 100,000 shares to settle accounts payable totaling approximately, $50,000. Further, the Company issued 196,619 shares for services provided.

           Liquidity and capital resources.

      Management recognizes the requirement for additional investment to execute the Company's business plan and complete the necessary manufacturing and research facilities. Financing transactions are currently being negotiated. These include an equity participation manufacturing joint venture, an equity investment in conjunction with a publicly financed trust fund and a long-term debt financing. There is no certainty that these fundings will be completed.

     Information regarding and factors affecting forward-looking statements. Forward-looking statements include statements concerning plans, goals, strategies, future events or performances and underlying assumptions and other statements, which are other than statements of historical fact. Certain statements contained herein are forward-looking statements and, accordingly, involve risk and uncertainties, which could cause the actual results or outcomes to differ materially from those expressed in the forward-looking statements. The Company's expectations, beliefs and projections are expressed in good faith and are believed by the Company to have a reasonable basis, including without limitations, management's examination of historical trends, data contained in the Company's records and other data available from third parties, but there can be no assurance that management's expectations, beliefs or projections will result, or be achieved, or accomplished.

 

 

 

 

 

Part II Other Information

Item 1 Legal

There were no new legal proceedings instituted by or against the Company since 1999. The following proceedings were instituted in the year 1999.

Three former employees of the Company's former subsidiary, FarWest Pump Co., filed a lawsuit in Maricopa County Superior Court alleging the Company failed to pay them certain wages and provide them with stock options. The former subsidiary of the Company, FarWest Pump, Inc., also entered the lawsuit and asserted various claims against the three former employees and their employer, Duncan Pump, Inc., including conversion, civil conspiracy, wrongful interference with contractual relationships, and violation of trade secrets.

The ex-employees attempted to recover approximately $250,000 in future wages and, in the aggregate, asked to be awarded stock options permitting the purchase of up to 630,000 shares of stock of the Company at $.25 per share. The employees also had requested that any damages awarded be trebled under Arizona law applicable to the failure of an employer to pay wages.

In late 2000, the Superior Court of Arizona Maricopa County ruled that the Company had no monetary liability to any of the three former employees of FarWest Pump Inc. The court ruled that the stock option claims for one of the three ex-employees be dismissed; however, the claims of the other two ex-employees for 205,000 stock options at $.25 per share would require further investigation.

The three ex-employees appealed the Superior Court's decision on all counts: During 2001, the Company vigorously contested the action. In January 2002, the Superior Court of Arizona Maricopa County granted the Company's request for a Summary Judgment on all monetary claims of the three ex-employees and granted summary judgment on the stock option claims for two ex-employees with stock option claims of 550,000. The Plaintiffs' filed a motion to amend the Judgment on behalf of the ex-employees. The Court on April 29, 2002 declined to set oral arguments and therefore, ruled, "IT IS ORDERED denying Plaintiffs' Motion to Amend Judgment."

The only remaining action to be resolved is the third ex-employees claim for 80,000 options at $0.25 per share.

Item 2 Changes in Securities

     During the quarter ended March 31, 2002, the Company issued 851,619 shares of common stock: 100,000 shares were issued in settlement of accounts payable, 196,619 shares were issued for services, 350,000 shares were issued upon receipt of a $175,000 note receivable and 205,000 shares of common stock were issued for cash. The shares issued were in reliance upon Section 4(2) of the Securities Act of 1933.

Item 3 Default upon senior securities.

     The Registrant does not have any outstanding debt or securities of this nature.

Item 4 Submission of matters to a vote of securities holders.

     NONE

Item 5 Other information.

     NONE

Item 6 Exhibits and Reports of Form 8-K.

     (a) Form 8-K was filed by the Registrant on April 18, 2002 relating to its change in auditors for the year ended December 31, 2001.

SIGNATURE

     Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Capacitive Deionization Technology Systems, Inc.

/s/ Dallas Talley

Dallas Talley

Chairman of the Board,

Chief Executive and Financial

Officer

Dated: May 14, 2002